Xie Jianteng, Wang Huizhen, Li Sheng, Zuo Yangyang, Wang Yanhui, Zhang Yifan, Liang Tiantian, Li Jing, Wang Liping, Feng Zhonglin, Ye Zhiming, Liang Xinling, Shi Wei, Wang Wenjian
Division of Nephrology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ther Apher Dial. 2019 Oct;23(5):409-417. doi: 10.1111/1744-9987.12791. Epub 2019 Mar 6.
The aim of this study is to evaluate the safety of low-volume tidal peritoneal dialysis (TPD) and intermittent peritoneal dialysis (IPD) in ESRD patients initiating automated peritoneal dialysis (APD) after an acute catheter insertion. Clinical outcomes of patients who received either TPD or IPD using an APD system were compared in a randomized, open-label, prospective control study in a single-center setting. From May 2011 to May 2013, 49 patients were enrolled and 27 patients received low-volume TPD treatment, whereas 22 patients underwent low-volume IPD right after Tenckhoff catheter insertion. The incidence of complications during the 14-day APD treatment were observed. After APD treatment, all the patients were transferred to continuous ambulatory peritoneal dialysis and followed up for 2 years. The IPD group demonstrated a significantly higher incidence of catheter-related complications (omental wrapping 27.3% vs. 0% and suction pain 18.2% vs. 0%) than the TPD group after adjusting for age, gender, baseline diabetes, systolic blood pressure, BMI, and the experience of the operators. However, the short duration of APD treatment with either IPD or TPD mode did not affect the long-time technical survival. In patients immediately after catheter insertion, low-volume TPD mode demonstrated a lower incidence of catheter-related complications compared to IPD. Although our results provided evidence that TPD is a preferable APD mode for this specific population, definitive conclusions about TPD benefit cannot be made, owing to early termination of the trial.
本研究的目的是评估在急性置管后开始接受自动化腹膜透析(APD)的终末期肾病(ESRD)患者中,小容量潮式腹膜透析(TPD)和间歇性腹膜透析(IPD)的安全性。在一项单中心、随机、开放标签、前瞻性对照研究中,比较了使用APD系统接受TPD或IPD治疗的患者的临床结局。2011年5月至2013年5月,共纳入49例患者,其中27例接受小容量TPD治疗,22例在Tenckhoff导管插入后立即接受小容量IPD治疗。观察14天APD治疗期间的并发症发生率。APD治疗后,所有患者均转为持续性非卧床腹膜透析,并随访2年。在调整年龄、性别、基线糖尿病、收缩压、体重指数和操作者经验后,IPD组导管相关并发症的发生率(大网膜包裹27.3%对0%,抽吸痛18.2%对0%)显著高于TPD组。然而,IPD或TPD模式下APD治疗的短疗程并未影响长期技术生存率。在导管插入后的患者中,与IPD相比,小容量TPD模式导管相关并发症的发生率较低。尽管我们的结果表明TPD是这一特定人群更合适的APD模式,但由于试验提前终止,无法得出关于TPD益处的确切结论。